GBM38 GBM Model
GBM38, a Patient-Derived Xenograft (PDX) model, offers a comprehensive view of brain cancer. Dive into research and treatment development with this invaluable tool for the scientific community. PDX models like GBM38 serve as essential platforms for preclinical drug discovery. By preserving the genetic and histological characteristics of the patient tumor, GBM38 enables researchers to test a wide range of drug candidates efficiently. This accelerates the development of targeted therapies, ultimately benefiting brain cancer patients.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM38
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GBM38 Survival
Survival of orthotopic intracranial implanted GBM38 in Nu/Nu mice (n=5)
